Evaluation of a novel absorbable mesh in a porcine model of abdominal wall repair
Recommended Citation
Mlodinow AS, Yerneni K, Hasse ME, Cruikshank T, Kuzycz MJ, Ellis MF. Evaluation of a Novel Absorbable Mesh in a Porcine Model of Abdominal Wall Repair. Plast Reconstr Surg Glob Open. 2021;9(5):e3529. Published 2021 May 25. doi:10.1097/GOX.0000000000003529
Abstract
Bioabsorbable meshes have seen increasing clinical use to reinforce soft tissue, and exist on a spectrum of strength loss versus absorption: several retain their strength for months, but remain in situ for years. Others lose strength fully by 6 weeks. An intermediate profile, with some strength for 3 -4 months, but consistent absorption in less than a year, may be an optimal balance of near-term support and long-term safety. In this large animal study, we evaluate such a mesh (DuraSorb, SIA), assessing its utility in a porcine model of abdominal wall repair.
Methods: Two full-thickness defects were created in the abdominal walls of nine Yucatan swine via midline approach and repaired preperitoneally with either DuraSorb or long-lasting control mesh (TIGR, Novus Scientific). At 30 days, 3 months, and 1 year, the implantations were assessed by clinical pathology, post-necropsy histopathology, and burst strength testing.
Results: No device-associated complications were found in vivo, at necropsy, or histologically. DuraSorb was well-integrated and vascularized by 30 days. DuraSorb demonstrated minimal/mild inflammation and fibroplasia, and lower inflammatory scores when compared with TIGR at all time points (P < 0.05). Burst strength of the repair sites was higher than adjacent abdominal wall at all time points (P < 0.05).
Conclusions: DuraSorb provided durable long-term support, minimal inflammation, and consistent absorption in this porcine model of abdominal wall repair, as compared to a long-term control. Clinical data is needed, but these results suggest that this mesh provides adequate structural support while potentially reducing long-term device reactions.
Document Type
Article
PubMed ID
34881139
Affiliations
Aurora Medical Center, Kenosha